|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,960.50 GBX | +1.24% |
|
+1.50% | +7.45% |
| 06/08 | LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors | CI |
| 06/08 | US FDA approves first mRNA flu shot from Moderna | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- GSK Stock
- Consensus GSK plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
